Management of advanced prostate cancer. ([2018])

• Record Type: Book
• Further Information: Note: Choung Soo Kim, editor.
• Editors: Kim, Choung Soo
• Contents: Intro; Preface; Contents; Part I: Surgery for Advanced Prostate Cancer; 1: Natural History ofHigh-Risk Prostate Cancer; 1.1 Introduction; 1.2 The Definition ofHigh-Risk Prostate Cancer; 1.3 Risk Factors forHigh-Risk Prostate Cancer; 1.4 Natural History ofHigh-Risk Prostate Cancer; 1.4.1 Localized or Locally Advanced High-Risk Prostate Cancer; 1.4.2 Hormone-Naïve Metastatic Prostate Cancer; 1.4.3 Castration-Resistant Prostate Cancer; 1.5 Summary; References; 2: Identifying theBest Candidate forRadical Prostatectomy inHigh-Risk Prostate Cancer; 2.1 Introduction. 2.2 RP forHigh-Grade Cancer2.3 RP forT3/4 N0 M0 Disease; 2.4 RP forNode-Positive Disease; 2.5 The Efficacy ofRP over External Beam Radiation Therapy (EBRT) withor Without ADT (Androgen Deprivation Therapy); 2.6 Safety ofRP Compare toEBRT (with or Without ADT); 2.7 RP inElderly Patients; 2.8 Recent Efforts forIdentifying theBetter Candidate forRP Among Patients withHigh-ƯRisk Prostate Cancer; 2.9 Summary; References; 3: Neoadjuvant Therapy Prior toRadical Prostatectomy; 3.1 Introduction; 3.2 Neoadjuvant Hormonal Therapy; 3.3 Neoadjuvant Chemotherapy withor Without ADT. 3.4 Neoadjuvant Therapy Using Novel Medicines3.5 Summary; References; 4: Robot-Assisted Radical Prostatectomy forHigh-Risk Prostate Cancer; 4.1 Introduction; 4.2 What Is High-Risk PCa?; 4.3 RARP forHigh-Risk PCa; 4.3.1 Nerve Sparing inHigh-Risk PCa During RARP; 4.3.2 Lymph Node Dissection inHigh-Risk PCa During RARP; 4.3.3 Perioperative Morbidity During RARP; 4.4 Outcomes ofRARP forHigh-ƯRisk PCa; 4.4.1 Oncologic Outcomes ofRARP forHigh-Risk PCa; 4.4.2 Functional Outcomes ofRARP forHigh-Risk PCa; References; 5: Pelvic Lymphadenectomy forHigh-Risk Prostate Cancer. 5.1 Current Indication ofPelvic Lymphadenectomy inHigh-ƯRisk Prostate Cancer5.2 Extent ofPelvic Lymphadenectomy (Limited Vs. Extended); 5.3 Robotic Surgery andPelvic Lymphadenectomy; 5.4 Clinical Outcome ofPelvic Lymphadenectomy; 5.5 Complication ofPelvic Lymphadenectomy; 5.6 Summary; References; 6: Adjuvant Therapy inLocally Advanced Prostate Cancer; 6.1 Introduction; 6.2 Definition; 6.3 General Guidelines by NCCN; 6.4 RP forLocally Advanced PCa; 6.5 RT inLocally Advanced PCa; 6.6 Multimodality Treatment inLocally Advanced PCa; 6.7 Adjuvant Postoperative RT. 6.8 Adjuvant HT6.9 Adjuvant Chemotherapy; 6.10 Summary; References; 7: Role ofRadical Prostatectomy intheManagement ofMetastatic Prostate Cancer; 7.1 Classic Role ofRadical Prostatectomy forPalliative Local Symptom Control; 7.2 Feasibility ofRadical Prostatectomy inMetastatic Prostate Cancer; 7.3 Possible Rationale forCytoreductive Radical Prostatectomy inMetastatic Prostate Cancer; 7.4 Indirect Evidence Supporting theEffectiveness ofCytoreductive Radical Prostatectomy.
• Publisher Details: Singapore : Springer
• Publication Date: 2018
• Copyright Date: 2018
• Extent: 1 online resource
• Subjects: 616.99/463; Prostate -- Cancer; HEALTH & FITNESS -- Diseases -- General; MEDICAL -- Clinical Medicine; MEDICAL -- Diseases; MEDICAL -- Evidence-Based Medicine; MEDICAL -- Internal Medicine; Prostate -- Cancer; Surgical Oncology; Electronic books; Electronic books
• Languages: English
• ISBNs: 9789811069437; 9811069433; 9811069425; 9789811069420
• Related ISBNs: 9789811069420; 9811069425
• Notes: Note: Includes bibliographical references.; Note: Vendor-supplied metadata.
• Access Rights: Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
• Access Usage: Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.